Releasing Bioactive Compounds from Brown Seaweed with Novel Cold-Adapted Alginate Lyase and Alcalase

Mar Drugs. 2023 Mar 27;21(4):208. doi: 10.3390/md21040208.

Abstract

Seaweeds are considered to be third-generation renewable biomasses, the comprehensive utilization of which has drawn increasing attention in recent years. A novel cold-active alginate lyase (VfAly7) was identified from Vibrio fortis and biochemically characterized for brown seaweed utilization. The alginate lyase gene was high-level expressed in Pichia pastoris, with an enzyme yield of 560 U/mL and a protein content of 9.8 mg/mL by high-cell density fermentation. The recombinant enzyme was most active at 30 °C and pH 7.5, respectively. VfAly7 was a bifunctional alginate lyase with both poly-guluronate and poly-mannuronate hydrolysis activities. On the basis of VfAly7, a bioconversion strategy for the utilization of brown seaweed (Undaria pinnatifida) was developed. The obtained AOSs showed stronger prebiotic activity towards tested probiotics when compared to that of commercial fructooligosaccharides (FOSs), while the obtained protein hydrolysates displayed strong xanthine oxidase inhibitory activity with IC50 of 3.3 mg/mL. This study provided a novel alginate lyase tool as well as a biotransformation route for the utilization of seaweeds.

Keywords: Pichia pastoris; Undaria pinnatifida; alginate lyase; alginate oligosaccharide; protein hydrolysaste.

MeSH terms

  • Alginates / metabolism
  • Hydrogen-Ion Concentration
  • Polysaccharide-Lyases / metabolism
  • Seaweed* / chemistry
  • Substrate Specificity
  • Subtilisins / metabolism

Substances

  • poly(beta-D-mannuronate) lyase
  • Subtilisins
  • Polysaccharide-Lyases
  • Alginates